These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3910659)

  • 1. Moyamoya in sickle cell disease demonstrated by DSA and Hexabrix.
    Ramsewak W; Gill G; Lo R
    J Can Assoc Radiol; 1985 Dec; 36(4):332-3. PubMed ID: 3910659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moya moya disease: use of digital subtraction angiography in its diagnosis.
    Hasuo K; Tamura S; Kudo S; Uchino A; Carlos R; Matsushima T; Kurokawa T; Kitamura K; Matsuura K
    Radiology; 1985 Oct; 157(1):107-11. PubMed ID: 3898215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal iodine concentration in digital subtraction arteriography.
    Norman D; Brant-Zawadzki M; Gould RG; Newton TH
    Invest Radiol; 1984; 19(6 Suppl):S368-70. PubMed ID: 6392167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind clinical comparison of Hexabrix and Renografin-76 for intravenous digital subtraction angiography.
    Turski PA; Gentry LR; Matozzi F; Verma S
    Invest Radiol; 1984; 19(6 Suppl):S363-5. PubMed ID: 6392165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic side effects of meglumine ioglicate, meglumine sodium ioxaglate and iohexol in aortofemoral angiography: comparison of a high-osmolar and two low-osmolar radiological contrast media.
    Wiebe V; Straub H
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():78-84. PubMed ID: 6139084
    [No Abstract]   [Full Text] [Related]  

  • 6. Contrast media tonicity. Part II. Isotonic ioxaglate vs. standard renografin for IV-DSA evaluation of the carotid bifurcation, a double-blind prospective clinical trial.
    Burbank FH; Bradley BR; Yegnashankaran S; Enzmann DR
    Invest Radiol; 1986 Apr; 21(4):340-7. PubMed ID: 3516921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of hexabrix and Renografin 60 in peripheral arteriography.
    Sacks BA; Ellison HP; Bartek S; Vine HS; Palestrant AM
    AJR Am J Roentgenol; 1983 May; 140(5):975-7. PubMed ID: 6601445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cerebral angiography with a new low osmolarity contrast medium (Hexabrix). Analysis of 3500 cerebral angiograms with 7 contrast media].
    Bartko D; Brezná M; Koník I; Dornetzhuberová M
    Cesk Neurol Neurochir; 1982 Jan; 45(1):41-8. PubMed ID: 7060172
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative trial of sodium meglumine ioxaglate (Hexabrix) and iopamidol (Niopam) for cerebral angiography.
    Molyneux AJ; Sheldon PW; Yates DA
    Br J Radiol; 1982 Dec; 55(660):881-4. PubMed ID: 6756533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind clinical study comparing tolerability, safety, and efficacy of Hexabrix and Renografin-76 for intravenous subtraction angiography.
    Nelson JA; Sherry RA
    Invest Radiol; 1984; 19(6 Suppl):S366-7. PubMed ID: 6392166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omnipaque vs. Hexabrix in intravenous DSA of the carotid arteries: randomized double-blind crossover study.
    Nakstad PH; Bakke SJ; Kjartansson O; von Krogh J
    AJNR Am J Neuroradiol; 1986; 7(2):303-4. PubMed ID: 3082163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radionuclide cerebral angiography in moyamoya disease.
    Maeda T; Mori H; Hisada K; Sugino M
    Clin Nucl Med; 1979 Dec; 4(12):513-5. PubMed ID: 527289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital subtraction angiography in pediatric cerebrovascular occlusive disease.
    Faerber EN; Griska LA; Swartz JD; Capitanio MA; Popky GL
    Radiology; 1984 Aug; 152(2):391-4. PubMed ID: 6377384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-arterial digital subtraction angiography of the carotid arteries. Special reference to contrast media.
    Nakstad P; Bakke SJ; Kjartansson O; Nyhus S
    Neuroradiology; 1986; 28(3):195-8. PubMed ID: 3523283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability and efficacy of Hexabrix in cerebral angiography.
    Norman D; Brant-Zawadzki M; Sobel D
    Invest Radiol; 1984; 19(6 Suppl):S306-7. PubMed ID: 6392158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iohexol and iopromide--two new non-ionic water-soluble radiographic contrast media: randomized, intraindividual double-blind study versus ioxaglate in peripheral angiography.
    Hagen B
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():107-14. PubMed ID: 6139064
    [No Abstract]   [Full Text] [Related]  

  • 17. Magnification angiography in moyamoya disease: new observations on collateral vessels.
    Takahashi M
    Radiology; 1980 Aug; 136(2):379-86. PubMed ID: 7403514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The advantage of coronal scanning in cerebral computed angiotomography for diagnosis of moyamoya disease.
    Asari S; Satoh T; Sakurai M; Yamamoto Y; Sadamoto K
    Radiology; 1982 Dec; 145(3):709-11. PubMed ID: 7146400
    [No Abstract]   [Full Text] [Related]  

  • 19. A study of the effect of sodium/meglumine ioxaglate (Hexabrix) on thyroid function.
    Grainger RG; Pennington GW
    Br J Radiol; 1981 Sep; 54(645):768-72. PubMed ID: 7296204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arteriography with ioxaglate (Hexabrix), a new low-osmolar contrast medium. A comparative study on amidotrizoate (Urografin-meglumine) with regard to subjective discomforts].
    Jensen KK; Freiberg H
    Ugeskr Laeger; 1981 Mar; 143(11):673-4. PubMed ID: 7281276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.